HHS Secretary Robert F. Kennedy Jr. took the top spot in this year's Shkreli Awards from the Lown Institute. Kennedy's act ...

Martin Shkreli sets a $100 target for QCLS, citing Microsoft's new Nature paper to argue that optical computing is the future ...

Investor Martin Shkreli's big biotech short position is blowing up after the stock's monumental rally over the past week.

While comparing U.S. equity market returns over the past 35 years with those of France and Japan, investor Martin Shkreli ...

Named for infamous ‘pharma bro’ Martin Shkreli, a former hedge fund manager who acquired a pharmaceuticals company and then ...

Martin Shkreli says QCLS stock could hit $100 in the near-term. He has fairly recently been proven wrong on Capricor Therapeutics.

Shkreli had earlier announced an investment in the company and expressed his desire to become the CEO. ・Trading was twice ...

Q/C Technologies welcomes Martin as part of its expanding advisory team alongside James Altucher, further strengthening the Company’s depth of expertise across computing, AI, and blockchain ...

Shkreli shared his bullish stance on the photonic/optical computing company via social media platform X, setting a near-term price target of $100 for the stock. He expressed conviction that optical ...

Investing.com -- Q/C Technologies, Inc. (NASDAQ:QCLS) stock surged 20% Tuesday morning after the quantum-class computing company announced the appointment of controversial figure Martin Shkreli as a ...

Q/C Technologies, Inc. (NASDAQ:QCLS) saw its stock surge 20% on Tuesday morning after the quantum-class computing firm ...

Capricorn Therapeutics stock soared after the biotech firm announced positive deramiocel Phase 3 trial results. But CAPR ...